Previous Close | 102.00 |
Open | 101.70 |
Bid | 102.10 x 21100 |
Ask | 102.20 x 8200 |
Day's Range | 101.60 - 102.90 |
52 Week Range | 81.35 - 122.90 |
Volume | |
Avg. Volume | 113,752 |
Market Cap | 3.533B |
Beta (5Y Monthly) | 0.90 |
PE Ratio (TTM) | 29.40 |
EPS (TTM) | 3.48 |
Earnings Date | Jul 11, 2024 |
Forward Dividend & Yield | 1.25 (1.23%) |
Ex-Dividend Date | Jun 06, 2024 |
1y Target Est | 89.60 |
Gerresheimer AG ( ETR:GXI ), might not be a large cap stock, but it saw a decent share price growth of 17% on the XTRA...
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has entered into a partnership with the US digital health company RxCap and acquired a minority stake. Under the terms of the agreement, Gerresheimer's subsidiary Centor will receive the exclusive distribution rights for pharmacies in the U.S. for adherence solutions by RxCap, consisting of connected prescription vial closure devices and complementary cloud-based softwa
Shareholders might have noticed that Gerresheimer AG ( ETR:GXI ) filed its quarterly result this time last week. The...